Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Relay Therapeutics, Inc. (RLAY) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/29/2023 4 Patel Sanjiv (President and CEO) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Granted 1,662 shares @ $10.68, valued at $17.8k
09/29/2023 4 Rahmer Peter (See remarks) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Granted 1,662 shares @ $10.68, valued at $17.8k
Sold 244 shares @ $8.38, valued at $2k
09/29/2023 4 Catinazzo Thomas (CFO) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 294 shares @ $8.38, valued at $2.5k
09/29/2023 4 Adams Brian (Chief Legal Officer) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 294 shares @ $8.38, valued at $2.5k
07/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/28/2023 4 Rahmer Peter (See remarks) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 244 shares @ $12.12, valued at $3k
06/28/2023 4 Catinazzo Thomas (CFO) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 294 shares @ $12.12, valued at $3.6k
06/28/2023 4 Bergstrom Donald A (President, R&D) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 647 shares @ $12.12, valued at $7.8k
06/28/2023 4 Adams Brian (Chief Legal Officer) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 294 shares @ $12.12, valued at $3.6k
06/01/2023 4 HILL LINDA A (Director) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Granted 66,055 options to buy @ $11.14, valued at $735.9k
06/01/2023 4 INGRAM DOUGLAS S (Director) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Granted 66,055 options to buy @ $11.14, valued at $735.9k
06/01/2023 4 Kathiresan Sekar (Director) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Granted 66,055 options to buy @ $11.14, valued at $735.9k
06/01/2023 4 Murcko Mark (Director) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Granted 66,055 options to buy @ $11.14, valued at $735.9k
06/01/2023 4 Rubin Jami (Director) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Granted 66,055 options to buy @ $11.14, valued at $735.9k
06/01/2023 4 Shawver Laura (Director) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Granted 66,055 options to buy @ $11.14, valued at $735.9k
06/01/2023 4 Borisy Alexis (Director) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Granted 66,055 options to buy @ $11.14, valued at $735.9k
06/01/2023 4 Rahmer Peter (See remarks) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Granted 161,818 shares @ $0
06/01/2023 4/A Rahmer Peter (See remarks) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 1,657 shares @ $11.16, valued at $18.5k
06/01/2023 4/A Catinazzo Thomas (CFO) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 2,012 shares @ $11.16, valued at $22.5k
06/01/2023 4/A Bergstrom Donald A (President, R&D) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 2,850 shares @ $11.16, valued at $31.8k
06/01/2023 4/A Adams Brian (Chief Legal Officer) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 1,936 shares @ $11.16, valued at $21.6k
05/26/2023 4 Shawver Laura (Director) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Gifted 12,099 shares @ $0
05/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/01/2023 4 Catinazzo Thomas (CFO) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 863 shares @ $11.16, valued at $9.6k
05/01/2023 4 Bergstrom Donald A (President, R&D) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 1,383 shares @ $11.16, valued at $15.4k
05/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/09/2023 4 Patel Sanjiv (President and CEO) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 14,000 shares @ $21.45, valued at $300.3k
Sold 14,000 shares @ $20.98, valued at $293.7k
Sold 14,000 shares @ $20.55, valued at $287.7k
Exercised 14,000 options to buy @ $5.04, valued at $70.6k
Exercised 14,000 options to buy @ $5.04, valued at $70.6k
Exercised 14,000 options to buy @ $5.04, valued at $70.6k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy